Despite all their talk of more strategic exploitation of data over the last ten to 15 years, the life sciences remain significantly behind other industries in achieving this.
With AI now seen as an important means to transform workflow, the data transformation imperative is more critical than ever, says Ian Crone, ArisGlobal’s VP Europe & APAC Regulatory Solutions, reporting on a recent panel discussion on the topic.
In Europe, ISO’s IDMP standards for medicinal product identification have been on the agenda for life sciences for well over a decade now. Yet refining the detail has taken too long, deadlines have slipped, and as momentum has faltered companies have failed to capitalise on the inherent benefits of having better, richer and more reliable data in a more reusable format.
Check out the rest of the feature here
